Skip to main content
Log in

Ipilimumab/nivolumab

Various toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Jeong SM, et al. From metastatic melanoma to complete response in seven months: The power of combined checkpoint immunotherapy. Journal of Investigative Medicine 66: 442, No. 2, Feb 2018 [abstract] - USA

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ipilimumab/nivolumab. Reactions Weekly 1696, 216 (2018). https://doi.org/10.1007/s40278-018-44404-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44404-9

Navigation